Skip to content

Novel biomarker discovery and screening for patients with depression

A study on the discovery and screening of novel biomarkers in patients with depression

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090787
Enrollment
Unknown
Registered
2024-10-14
Start date
2024-10-14
Completion date
Unknown
Last updated
2024-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Observation Group:None
Control group:None

Sponsors

Nanjing Brain Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Fulfills diagnostic criteria for depression; (2) The patients were of any gender and aged between 12 and 80 years old; (3) Subjects were conscious, able to understand and cooperate in completing the questionnaire, with clear responses and informed consent to the study.

Exclusion criteria

Exclusion criteria: (1) Those with mood disorders due to somatic or organic brain disorders; (2) With a history of suicide attempts, history of refractory depression, history of seizures, bipolar disorder, schizophrenia, or schizoaffective disorder.

Design outcomes

Primary

MeasureTime frame
general characteristics;

Secondary

MeasureTime frame
Depression Severity Rating Scale;protein index;Metabolites of intestinal flora;

Countries

China

Contacts

Public ContactQiao Huifen

Nanjing Brain Hospital

huifenaqiao@163.com+86 139 5177 1613

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026